HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

(99m)Tc-dextran scintigraphy to detect disease activity in patients with rheumatoid arthritis.

AbstractAIM:
To test the applicability of Tc-dextran joint scintigraphy in the assessment of disease activity in patients with rheumatoid arthritis (RA), and to compare it with the clinical disease activity scores and laboratory parameters.
METHODS:
Twenty-seven patients with RA were investigated using Tc-dextran joint scintigraphy. The images were evaluated semi-quantitatively and the regional uptakes of the radiopharmaceutical were calculated for the knee, wrist and ankle joints. The clinical and laboratory parameters were collected and fully analysed. An articular Ritchie index (a tender joint score), the number of swollen joints (Sw), the number of tender joints, the morning stiffness (h), the total Ritchie articular index (R), the visual analogue scale (VAS) and the Disease Activity Score (DAS) were determined for all patients.
RESULTS:
Compared with controls, patients with RA had significantly higher regional Tc-dextran uptake in the knee, wrist and ankle joints (P=0.001). The regional Tc-dextran uptake showed no correlation with the patient's age, gender, duration of disease, number of swollen joints (Sw), number of tender joints, morning stiffness (h), VAS, total Ritchie articular index and DAS, or any laboratory parameters. There was a significant correlation between the regional Tc-dextran uptake for individual joints and the articular Ritchie index of the right and left wrist (r=0.42, P=0.03; r=0.45, P=0.02), right and left knee (r=0.66, P<0.0001; r=0.80, P<0.0001) and right and left ankle (r=0.47, P=0.014; r=0.76, P<0.0001), respectively.
CONCLUSIONS:
This study demonstrates that Tc-dextran scintigraphy is a sensitive method to detect active joint inflammation and could be useful in the management of patients with RA.
AuthorsMeryem Kaya, Hakan Tuna, Mehmet Fatih Firat, Filiz Tuna, Gülay Seren, Omer Necmi Yigitbasi
JournalNuclear medicine communications (Nucl Med Commun) Vol. 25 Issue 6 Pg. 597-601 (Jun 2004) ISSN: 0143-3636 [Print] England
PMID15167520 (Publication Type: Clinical Trial, Comparative Study, Controlled Clinical Trial, Journal Article, Validation Study)
Chemical References
  • Dextrans
  • Organotechnetium Compounds
  • Radiopharmaceuticals
  • technetium Tc 99m dextran
Topics
  • Adult
  • Aged
  • Arthritis, Rheumatoid (classification, diagnosis, diagnostic imaging)
  • Dextrans
  • Female
  • Humans
  • Male
  • Middle Aged
  • Organotechnetium Compounds
  • Radionuclide Imaging
  • Radiopharmaceuticals
  • Severity of Illness Index

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: